Resonance Health Share Price and Company Fundamentals
Last traded: Today at 12:14 AM
Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices (SaMD) in the Asia Pacific, North America, Europe, the Middle East, and Africa. It operates through SaMD, Resonance Clinical, and TrialsWest segments. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFatSmart, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFatSmart into a consolidated report; and CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading. It also provides phantoms comprising FerriScan, R2*/T2*, T1CMR, and T2CMR phantoms for the calibration of MRI machines. In addition, the company operates as an imaging contract research organization that provides comprehensive proposal and project management support, site set-up, imaging charter development, clinical reports, data transfer agreements, and compliance services for clinical trial sponsors. It serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.
Key Metrics
PE ratio
-
PB ratio
2.35
Dividend yield
-
Beta
1.15
Market cap
$22.32M
Enterprise value
$21.18M
Company profile
| Industry / Sector | Health Information Services / Healthcare |
|---|---|
| Website | https://www.resonancehealth.com |
| Mailing address | 141 Burswood Road Level 1 Burswood WA 6100 Australia |
| Phone / Fax | 61 8 9286 5300 / 61 8 9286 5399 |
Dividends
More: Resonance Health Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Resonance Health paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RHT dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Resonance Health.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Andrew Duncan Harrison BCom (Hons), MAICD | CEO & Director | 54 | |
| Mr. Benjamin Carruthers | Chief Financial Officer | ||
| Mr. Mitchell M. Wells B.Com., B.Comm, L.L.B. | Company Secretary & Non Executive Director | 50 | |
| Mr. Gavin Pinto | Chief Technology Officer | ||
| Ms. Narelle Mounsey | General Manager of People & Culture | ||
| Dr. Wenjie Pang Ph.D. | Chief Scientific Officer Imaging & AI | ||
| Dr. Sherif Boulos Ph.D. | Chief Scientific Officer of Molecular |
Profitability and management effectiveness
Profit margin
-15.65%
Operating margin
-5.20%
Return on assets
-5.18%
Return on equity
-17.05%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Resonance Health is 22.32M and its enterprise value is 21.18M. The enterprise value to revenue ratio of RHT is 1.91. The enterprise value to EBITDA ratio of RHT is -15.04.
The RHT's stocks Beta value is 1.15 making it 15% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Resonance Health (RHT)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Pro Medicus (PME)
- Polynovo (PNV)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Resonance Health (ASX:RHT) Frequently Asked Questions
1. What is Resonance Health's Stock Symbol?
Resonance Health trades on ASX under the ticker symbol "RHT".
2. What is Resonance Health's stock price today?
One share of RHT stock can currently be purchased for approximately $0.047.
3. How can I contact Resonance Health?
Resonance Health's mailing address is 141 Burswood Road Level 1 Burswood WA 6100 Australia. The company can be reached via phone at 61 8 9286 5300.
4. What is Resonance Health's official website?
The official website of Resonance Health is https://www.resonancehealth.com.